España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Immunome
IMNM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$12.98
0.44
3.51%
At close: -
$13.09
0.11
0.85%
After Hours: 7:07 PM EDT
Get Report
Comment
Immunome (IMNM) Forecast
News
Earnings
Immunome (IMNM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Immunome (NASDAQ:IMNM) Stock
Immunome Stock (NASDAQ: IMNM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 08, 2024
Analyst Expectations For Immunome's Future
Benzinga Insights
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Avi Kapoor
Stephens & Co. Initiates Coverage On Immunome...
Benzinga Newsdesk
Tuesday, October 29, 2024
Immunome Presents Compelling Preclinical Data...
Benzinga Newsdesk
Friday, October 25, 2024
Wedbush Reiterates Outperform on Immunome, Ma...
Benzinga Newsdesk
Friday, October 18, 2024
Immunome To Present Poster Highlighting Precl...
Benzinga Newsdesk
Friday, October 11, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, October 07, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Tuesday, October 01, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Friday, September 13, 2024
Immunome To Present Poster With Updated Resul...
Benzinga Newsdesk
Tuesday, August 13, 2024
Wedbush Reiterates Outperform on Immunome, Ma...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Immunom...
Benzinga Newsdesk
Monday, August 12, 2024
Immunome Q2 EPS $(0.60) Misses $(0.39) Estima...
Benzinga Newsdesk
Monday, July 29, 2024
CORRECTION: Imunon Ticker Is "IMNN"
Benzinga Newsdesk
Thursday, July 25, 2024
Nectin Therapeutics Enters Global, Exclusive ...
Benzinga Newsdesk
Friday, May 31, 2024
Evaluating Immunome: Insights From 4 Financial Analysts
Benzinga Insights
Piper Sandler Initiates Coverage On Immunome ...
Benzinga Newsdesk
Wednesday, May 22, 2024
Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
Immunome shares are trading higher after a Fo...
Benzinga Newsdesk
Tuesday, May 21, 2024
Immunome shares are trading higher after a Fo...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Immunome Form 4 Filing Shows President And CE...
Benzinga Newsdesk
Friday, May 17, 2024
Immunome Promotes Max Rosett To CFO, Effectiv...
Benzinga Newsdesk
Tuesday, May 14, 2024
Immunome Q1 EPS $(2.51) Misses $(0.69) Estima...
Benzinga Newsdesk
Monday, May 13, 2024
CORRECTION: Immunome Did Not Report Q1 Earnin...
Benzinga Newsdesk
Tuesday, April 30, 2024
JP Morgan Initiates Coverage On Immunome with...
Benzinga Newsdesk
Monday, April 15, 2024
Guggenheim Initiates Coverage On Immunome wit...
Benzinga Newsdesk
Wednesday, April 03, 2024
Immunome Files For Shelf Of Up To 2.2M Shares...
Benzinga Newsdesk
Immunome Inc Filed Prospectus Relates To Prop...
Benzinga Newsdesk
Monday, April 01, 2024
Wedbush Maintains Outperform on Immunome, Rai...
Benzinga Newsdesk
Friday, March 29, 2024
Immunome Q4 Adj EPS $(0.15) Beats $(0.28) Est...
Benzinga Newsdesk
Thursday, March 28, 2024
Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
Piero Cingari
Friday, March 22, 2024
Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Monday, March 18, 2024
Immunome Selects Arrayjet's ArrayPlex Platfor...
Benzinga Newsdesk
Wednesday, February 28, 2024
Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
Erica Kollmann
Thursday, February 22, 2024
IMUNON, Inc. Announces IMNN-101 Preclinical D...
Benzinga Newsdesk
Tuesday, February 20, 2024
Immunome Recognizes Ayala Pharmaceuticals' An...
Benzinga Newsdesk
Wednesday, February 14, 2024
Immunome Prices Public Offering Of 10M Common...
Benzinga Newsdesk
Tuesday, February 13, 2024
Immunome Announces Proposed $200M Public Offe...
Benzinga Newsdesk
Tuesday, February 06, 2024
Immunome shares are trading higher after the ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Immunome To Acquire AL102 And AL101 Drug Cand...
Benzinga Newsdesk
Tuesday, January 23, 2024
Wedbush Maintains Outperform on Immunome, Rai...
Benzinga Newsdesk
Monday, January 08, 2024
Immunome, Zentalis Enter Exclusive, Worldwide...
Benzinga Newsdesk
Tuesday, December 26, 2023
Immunome shares are trading higher after the ...
Benzinga Newsdesk
Immunome To Acquire Antibody-Related Assets And Materials From Atreca; Under The Terms Of The Asset Purchase Agreement, Immunome Would Pay Atreca A $5.5M Upfront Payment And Up To $7M In Clinical Development Milestones
Happy Mohamed
Tuesday, December 19, 2023
Wedbush Initiates Coverage On Immunome with O...
Benzinga Newsdesk
Friday, November 10, 2023
Director at Immunome Acquires Company Stock Options Worth 40,696 Shares
Benzinga Insights
Thursday, November 09, 2023
Immunome Q3 EPS $(0.36) Up From $(0.75) YoY, ...
Benzinga Newsdesk
Wednesday, November 01, 2023
Chief Medical Officer at Immunome Acquires Company Stock Options Worth 400,000 Shares
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
